Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 29Myelodysplastic Syndromes 10Advanced Solid Tumors 8Leukemia, Myelomonocytic, Chronic 6Myeloproliferative Disorders 5Advanced Solid Tumor 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Neoplasms 4Advanced Solid Tumour 4Multiple Myeloma 3Lung Neoplasms 3Leukemia, Monocytic, Acute 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Thrombocythemia, Essential 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumor 2Small Cell Lung Carcinoma 2Recurrence 2Prostatic Neoplasms 2Primary Myelofibrosis 2Polycythemia Vera 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Acute 2Leukemia, Biphenotypic, Acute 2Breast Neoplasms 2Biliary Tract Neoplasms 2Advanced Malignant Solid Tumor 2

Interventions

Therapeutics 4Psilocybin 4Surveys and Questionnaires 3Interviews as Topic 2enzalutamide 1darolutamide 1apalutamide 1abacavir 1Standard of Care 1Relaxation Therapy 1Psychotherapy 1Psychosocial Intervention 1Practice Guidelines as Topic 1Physical Examination 1Palliative Care 1Niacin 1Music Therapy 1Mindfulness 1Methods 1Meditation 1Injections 1Focus Groups 1Exercise Test 1Ethanol 1Electroacupuncture 1Early Intervention, Educational 1Early Detection of Cancer 1Dignity Therapy 1Decision Support Techniques 1Culture Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depression × Injections × 90 days × Clear all
NCT07002034 2026-05-06

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Reunion Neuroscience Inc

Phase 2 Recruiting
100 enrolled

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡